Načítá se...
In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas
[Image: see text] Traditional chemotherapeutics used in cancer therapy do not preferentially accumulate in tumor tissues. The conjugation to delivery vehicles like antibodies or small molecules has been proposed as a strategy to increase the tumor uptake and improve the therapeutic window of these d...
Uloženo v:
| Vydáno v: | ACS Omega |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Chemical Society
2018
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6276201/ https://ncbi.nlm.nih.gov/pubmed/30533574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.8b02350 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|